✦ LIBER ✦

Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: Win, win, win?

✍ Scribed by Benner, Kent G.

Publisher: Wiley (John Wiley & Sons)
Year: 1999
Tongue: English
Weight: 36 KB
Volume: 5
Category: Article
ISSN: 1074-3022
DOI: 10.1002/lt.500050403

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of pretransplantation ursodeoxych

Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis

✍ Heathcote, E. Jenny ;Stone, Julie ;Cauch-Dudek, Karen ;Poupon, Raoul ;Chazouille 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 42 KB

As ursodeoxycholic acid (UDCA) delays the need for transplantation, this could result in patients with more comorbid disease, therefore more likely to have a worse outcome posttransplantation. The aim of this study is to compare posttransplantation outcome in patients who received UDCA versus placeb

Does antimitochondrial antibody status a

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation

✍ W R Kim; J J Poterucha; R A Jorgensen; K P Batts; H A Homburger; E R Dickson; R 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 1 views

rum. 1 In the past decade, two treatment modalities have Approximately 5% to 10% of patients with features otherbeen shown to be effective in the treatment for PBC, dewise consistent with primary biliary cirrhosis (PBC) lack antipending on the stage of the disease. For patients with less mitochondri

Ursodeoxycholic acid inhibits eosinophil

Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis

✍ Kiyoshi Yamazaki; Kazuyuki Suzuki; Atsushi Nakamura; Shunichi Sato; Keith D. Lin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 1 views

Eosinophilia is a distinctive feature of primary biliary cirrhosis (PBC), especially in its early stages. Intriguingly, treatment with ursodeoxycholic acid (UDCA) ameliorates eosinophilia as well as liver tests in patients with PBC. It remains unknown, however, whether eosinophils in PBC patients ar

Ten-year survival in ursodeoxycholic aci

Ten-year survival in ursodeoxycholic acid–treated patients with primary biliary cirrhosis

✍ Renée Eugénie Poupon; Anne-Marie Bonnand; Yves Chrétien; Raoul Poupon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 1 views

Clinical significance of serum bilirubin

Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis

✍ Anne-Marie Bonnand; E. Jenny Heathcote; Keith D. Lindor; Renée Eugénie Poupon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Atorvastatin in patients with primary bi

Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid

✍ Tatjana Stojakovic; Csilla Putz-Bankuti; Günter Fauler; Hubert Scharnagl; Martin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Statin therapy may target both hypercholesterolemia and cholestasis in primary biliary cirrhosis (PBC). However, little is known about the efficacy and safety of statins in PBC. The aim of this single-center study was therefore to prospectively examine the effects of atorvastatin on serum markers of